KLDO Projected Dividend Yield
Kaleido Biosciences Inc ( OTCBB : KLDO )Kaleido Biosciences is a clinical-stage healthcare company with an approach focused on utilizing the microbiome to treat disease and improve human health. Co.'s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the existing microbes. Co. has an approach to the discovery and development of MMTs, and its initial MMTs are targeted glycans. Each targeted glycan is an ensemble of complex carbohydrates that is intended to modulate microbial metabolism and community composition to drive a specific biological response. 20 YEAR PERFORMANCE RESULTS |
KLDO Dividend History Detail KLDO Dividend News KLDO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |